| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis S Sawcer, G Hellenthal, M Pirinen, CCA Spencer, NA Patsopoulos, ... Nature 476 (7359), 214, 2011 | 2342 | 2011 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis AH Beecham, NA Patsopoulos, DK Xifara, MF Davis, A Kemppinen, ... Nature genetics 45 (11), 1353, 2013 | 932 | 2013 |
| Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ... Neurology 64 (7), 1144-1151, 2005 | 840 | 2005 |
| Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, R Simmons, ... Bmj 327 (7410), 316, 2003 | 653 | 2003 |
| Gait and balance impairment in early multiple sclerosis in the absence of clinical disability CL Martin, BA Phillips, TJ Kilpatrick, H Butzkueven, N Tubridy, ... Multiple Sclerosis Journal 12 (5), 620-628, 2006 | 512 | 2006 |
| Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Australia and New Zealand Multiple Sclerosis Genetics Consortium Nature genetics 41 (7), 824, 2009 | 445 | 2009 |
| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 371 | 2018 |
| Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, BV Taylor, T Kilpatrick, ... Journal of neurology 254 (5), 581-590, 2007 | 369 | 2007 |
| Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci NA Patsopoulos, ... Annals of neurology 70 (6), 897-912, 2011 | 305 | 2011 |
| LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival H Butzkueven, JG Zhang, M Soilu-Hanninen, H Hochrein, F Chionh, ... Nature medicine 8 (6), 613-619, 2002 | 293 | 2002 |
| Onset seizures independently predict poor outcome after subarachnoid hemorrhage H Butzkueven, AH Evans, A Pitman, C Leopold, DJ Jolley, AH Kaye, ... Neurology 55 (9), 1315-1320, 2000 | 215 | 2000 |
| Brain health: time matters in multiple sclerosis G Giovannoni, H Butzkueven, S Dhib-Jalbut, J Hobart, G Kobelt, G Pepper, ... Multiple sclerosis and related disorders 9, S5-S48, 2016 | 197 | 2016 |
| A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis MS Stein, Y Liu, OM Gray, JE Baker, SC Kolbe, MR Ditchfield, GF Egan, ... Neurology 77 (17), 1611-1618, 2011 | 197 | 2011 |
| Geographical variations in sex ratio trends over time in multiple sclerosis M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ... PLOS one 7 (10), e48078, 2012 | 185 | 2012 |
| Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, L Vanopdenbosch, ... The Lancet Neurology 16 (3), 189-199, 2017 | 159 | 2017 |
| Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016 | 154 | 2016 |
| Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results H Butzkueven, L Kappos, F Pellegrini, M Trojano, H Wiendl, RN Patel, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (11), 1190-1197, 2014 | 145 | 2014 |
| Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians JP Rubio, J Stankovich, J Field, N Tubridy, M Marriott, C Chapman, ... Genes & Immunity 9 (7), 624-630, 2008 | 144 | 2008 |
| Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ... Annals of neurology 77 (3), 425-435, 2015 | 140 | 2015 |
| MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis H Butzkueven, J Chapman, E Cristiano, F Grand’Maison, M Hoffmann, ... Multiple Sclerosis Journal 12 (6), 769-774, 2006 | 140 | 2006 |
Bruce V Taylormenzies Research Institute Tasmania University of TasmaniaVerified email at utas.edu.au
